-
Something wrong with this record ?
Wnt signaling pathway in mammary gland development and carcinogenesis
G Turashvili, J Bouchal, G Burkadze, Z Kolar
Language English Country Switzerland
Document type Research Support, Non-U.S. Gov't, Review
Grant support
NR7844
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
Karger Journals
from 1990 to 2009
ProQuest Central
from 1995-05-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1995-05-01 to 2015-11-30
Health & Medicine (ProQuest)
from 1995-05-01 to 1 year ago
Public Health Database (ProQuest)
from 1995-05-01 to 2015-11-30
PubMed
17314492
DOI
10.1159/000098207
Knihovny.cz E-resources
- MeSH
- Humans MeSH
- Mammary Glands, Human metabolism growth & development MeSH
- Cell Transformation, Neoplastic genetics metabolism MeSH
- Breast Neoplasms genetics metabolism MeSH
- Wnt Proteins genetics metabolism MeSH
- Signal Transduction * physiology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
The signaling pathway mediated by Wingless-type (Wnt) proteins is highly conserved in evolution. This pivotal pathway is known to regulate cell fate decisions, cell proliferation, morphology, migration, apoptosis, differentiation and stem cell self-renewal. It currently includes the canonical or Wnt/beta-catenin pathway in which Wnt proteins bind to 'frizzled' receptors, which leads to downstream activation of gene transcription by beta-catenin. Second, the noncanonical or beta-catenin-independent pathways are now known to be mediated by three possible mechanisms: (1) the Wnt/Ca(2+) pathway, (2) the Wnt/G protein signaling pathway, and (3) the Wnt/PCP or planar cell polarity pathway. Wnt signaling is implicated at several stages of mammary gland growth and differentiation, and possibly in the involution of mammary gland following lactation. Recent evidence suggests the role of Wnt signaling in human breast cancer involves elevated levels of nuclear and/or cytoplasmic beta-catenin using immunohistochemistry, overexpression or downregulation of specific Wnt proteins, overexpression of CKII and sFRP4, downregulation of WIF-1 and sFRP1, as well as amplification of DVL-1. Further research is required to determine how Wnt signaling is involved in the development of different histological types of breast cancer and whether it promotes the viability of cancer stem cells or not. Copyright 2006 S. Karger AG, Basel.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13029048
- 003
- CZ-PrNML
- 005
- 20130930092416.0
- 007
- ta
- 008
- 130909s2006 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000098207 $2 doi
- 035 __
- $a (PubMed)17314492
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Turashvili, Gullisa $7 _AN040279 $u Laboratory of Molecular Pathology, Institute of Pathology, Palacky University, Olomouc, Czech Republic
- 245 10
- $a Wnt signaling pathway in mammary gland development and carcinogenesis / $c G Turashvili, J Bouchal, G Burkadze, Z Kolar
- 504 __
- $a Literatura $b 96
- 520 9_
- $a The signaling pathway mediated by Wingless-type (Wnt) proteins is highly conserved in evolution. This pivotal pathway is known to regulate cell fate decisions, cell proliferation, morphology, migration, apoptosis, differentiation and stem cell self-renewal. It currently includes the canonical or Wnt/beta-catenin pathway in which Wnt proteins bind to 'frizzled' receptors, which leads to downstream activation of gene transcription by beta-catenin. Second, the noncanonical or beta-catenin-independent pathways are now known to be mediated by three possible mechanisms: (1) the Wnt/Ca(2+) pathway, (2) the Wnt/G protein signaling pathway, and (3) the Wnt/PCP or planar cell polarity pathway. Wnt signaling is implicated at several stages of mammary gland growth and differentiation, and possibly in the involution of mammary gland following lactation. Recent evidence suggests the role of Wnt signaling in human breast cancer involves elevated levels of nuclear and/or cytoplasmic beta-catenin using immunohistochemistry, overexpression or downregulation of specific Wnt proteins, overexpression of CKII and sFRP4, downregulation of WIF-1 and sFRP1, as well as amplification of DVL-1. Further research is required to determine how Wnt signaling is involved in the development of different histological types of breast cancer and whether it promotes the viability of cancer stem cells or not. Copyright 2006 S. Karger AG, Basel.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a zvířata $7 D000818
- 650 02
- $a nádory prsu $x genetika $x metabolismus $7 D001943
- 650 02
- $a nádorová transformace buněk $x genetika $x metabolismus $7 D002471
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mléčné žlázy lidské $x metabolismus $x růst a vývoj $7 D042361
- 650 12
- $a signální transdukce $x fyziologie $7 D015398
- 650 02
- $a proteiny Wnt $x genetika $x metabolismus $7 D051153
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bouchal, Jan, $d 1973- $7 xx0034399 $u Laboratory of Molecular Pathology, Institute of Pathology, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Burkadze, George
- 700 1_
- $a Kolář, Zdeněk, $d 1953- $7 jn20000710256 $u Laboratory of Molecular Pathology, Institute of Pathology, Palacky University, Olomouc, Czech Republic
- 773 0_
- $t Pathobiology $x 1015-2008 $g Roč. 73, č. 5 (2006), s. 213-223 $p Pathobiology $w MED00003703
- 773 0_
- $p Pathobiology $g 73(5):213-23, 2006 $x 1015-2008
- 910 __
- $a ABA008 $b A 898 $y 3 $z 0
- 990 __
- $a 20130909152347 $b ABA008
- 991 __
- $a 20130930092931 $b ABA008
- 999 __
- $a ok $b bmc $g 993080 $s 827482
- BAS __
- $a 3
- BMC __
- $a 2006 $b 73 $c 5 $d 213-223 $i 1015-2008 $m Pathobiology $x MED00003703 $n Pathobiology
- GRA __
- $a NR7844 $p MZ0
- LZP __
- $a 2013-09/dpbo